Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria
Daniel Fernandez-Ruiz,Lei Shong Lau,Nazanin Ghazanfari,Claerwen M Jones,Wei Yi Ng,Gayle M Davey,Dorothee Berthold,Lauren Holz,Yu Kato,Matthias H Enders,Ganchimeg Bayarsaikhan,Sanne H Hendriks,Lianne I M Lansink,Jessica A Engel,Megan S F Soon,Kylie R James,Anton Cozijnsen,Vanessa Mollard,Alessandro D Uboldi,Christopher J Tonkin,Tania F de Koning-Ward,Paul R Gilson,Tsuneyasu Kaisho,Ashraful Haque,Brendan S Crabb,Francis R Carbone,Geoffrey I McFadden,William R Heath
DOI: https://doi.org/10.4049/jimmunol.1700186
2017-12-15
Abstract:We describe an MHC class II (I-Ab)-restricted TCR transgenic mouse line that produces CD4+ T cells specific for Plasmodium species. This line, termed PbT-II, was derived from a CD4+ T cell hybridoma generated to blood-stage Plasmodium berghei ANKA (PbA). PbT-II cells responded to all Plasmodium species and stages tested so far, including rodent (PbA, P. berghei NK65, Plasmodium chabaudi AS, and Plasmodium yoelii 17XNL) and human (Plasmodium falciparum) blood-stage parasites as well as irradiated PbA sporozoites. PbT-II cells can provide help for generation of Ab to P. chabaudi infection and can control this otherwise lethal infection in CD40L-deficient mice. PbT-II cells can also provide help for development of CD8+ T cell-mediated experimental cerebral malaria (ECM) during PbA infection. Using PbT-II CD4+ T cells and the previously described PbT-I CD8+ T cells, we determined the dendritic cell (DC) subsets responsible for immunity to PbA blood-stage infection. CD8+ DC (a subset of XCR1+ DC) were the major APC responsible for activation of both T cell subsets, although other DC also contributed to CD4+ T cell responses. Depletion of CD8+ DC at the beginning of infection prevented ECM development and impaired both Th1 and follicular Th cell responses; in contrast, late depletion did not affect ECM. This study describes a novel and versatile tool for examining CD4+ T cell immunity during malaria and provides evidence that CD4+ T cell help, acting via CD40L signaling, can promote immunity or pathology to blood-stage malaria largely through Ag presentation by CD8+ DC.